Copyright Reports & Markets. All rights reserved.

Global Embolization Particle Market Research Report 2012-2024

Buy now

Table of Contents

    1 Market Overview

    • 1.1 Objectives of Research
      • 1.1.1 Definition
      • 1.1.2 Specifications
    • 1.2 Market Segment
      • 1.2.1 by Type
        • 1.2.1.1 Microspheres
        • 1.2.1.2 Particles (e.g. PVA Particles, Gelfoam Particles)
        • 1.2.1.3 Drug-eluting Beads (DEBs)
        • 1.2.1.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
      • 1.2.2 by Application
        • 1.2.2.1 Uterine Fibroid Embolization
        • 1.2.2.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
        • 1.2.2.3 Liver Tumor Embolization
        • 1.2.2.4 Trauma Embolization
        • 1.2.2.5 Others
      • 1.2.3 by Regions

    2 Industry Chain

    • 2.1 Industry Chain Structure
    • 2.2 Upstream
    • 2.3 Market
      • 2.3.1 SWOT
      • 2.3.2 Dynamics

    3 Environmental Analysis

    • 3.1 Policy
    • 3.2 Economic
    • 3.3 Technology
    • 3.4 Market Entry

    4 Market Segmentation by Type

    • 4.1 Market Size
      • 4.1.1 Microspheres Market, 2013-2018
      • 4.1.2 Particles (e.g. PVA Particles, Gelfoam Particles) Market, 2013-2018
      • 4.1.3 Drug-eluting Beads (DEBs) Market, 2013-2018
      • 4.1.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Market, 2013-2018
    • 4.2 Market Forecast
      • 4.2.1 Microspheres Market Forecast, 2019-2024
      • 4.2.2 Particles (e.g. PVA Particles, Gelfoam Particles) Market Forecast, 2019-2024
      • 4.2.3 Drug-eluting Beads (DEBs) Market Forecast, 2019-2024
      • 4.2.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Market Forecast, 2019-2024

    5 Market Segmentation by Application

    • 5.1 Market Size
      • 5.1.1 Uterine Fibroid Embolization Market, 2013-2018
      • 5.1.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Market, 2013-2018
      • 5.1.3 Liver Tumor Embolization Market, 2013-2018
      • 5.1.4 Trauma Embolization Market, 2013-2018
      • 5.1.5 Others Market, 2013-2018
    • 5.2 Market Forecast
      • 5.2.1 Uterine Fibroid Embolization Market Forecast, 2019-2024
      • 5.2.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Market Forecast, 2019-2024
      • 5.2.3 Liver Tumor Embolization Market Forecast, 2019-2024
      • 5.2.4 Trauma Embolization Market Forecast, 2019-2024
      • 5.2.5 Others Market Forecast, 2019-2024

    6 Market Segmentation by Region

    • 6.1 Market Size
      • 6.1.1 Asia-Pacific
        • 6.1.1.1 Asia-Pacific Market, 2012-2018
        • 6.1.1.2 Asia-Pacific Market by Type
        • 6.1.1.3 Asia-Pacific Market by Application
      • 6.1.2 North America
        • 6.1.2.1 North America Market, 2012-2018
        • 6.1.2.2 North America Market by Type
        • 6.1.2.3 North America Market by Application
      • 6.1.3 Europe
        • 6.1.3.1 Europe Market, 2012-2018
        • 6.1.3.2 Europe Market by Type
        • 6.1.3.3 Europe Market by Application
      • 6.1.4 South America
        • 6.1.4.1 South America Market, 2012-2018
        • 6.1.4.2 South America Market by Type
        • 6.1.4.3 South America Market by Application
      • 6.1.5 Middle East & Africa
        • 6.1.5.1 Middle East & Africa Market, 2012-2018
        • 6.1.5.2 Middle East & Africa Market by Type
        • 6.1.5.3 Middle East & Africa Market by Application
    • 6.2 Market Forecast
      • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
      • 6.2.2 North America Market Forecast, 2019-2024
      • 6.2.3 Europe Market Forecast, 2019-2024
      • 6.2.4 South America Market Forecast, 2019-2024
      • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

    7 Market Competitive

    • 7.1 Global Market by Vendors
    • 7.2 Market Concentration
    • 7.3 Price & Factors
    • 7.4 Marketing Channel

    8 Major Vendors

    • 8.1 Sirtex Medical
    • 8.2 Merit Medical
    • 8.3 Cook Medical
    • 8.4 BTG Medical
    • 8.5 Boston Scientific Corporation
    • 8.6 Terumo Corporation
    • 8.7 HENGRUI Medical
    • 8.8 INterface BIOmaterials B.V.
    • 8.9 Alicon

    9 Conclusion

    Summary
    The global Embolization Particle market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Microspheres
    Particles (e.g. PVA Particles, Gelfoam Particles)
    Drug-eluting Beads (DEBs)
    Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Sirtex Medical
    Merit Medical
    Cook Medical
    BTG Medical
    Boston Scientific Corporation
    Terumo Corporation
    HENGRUI Medical
    INterface BIOmaterials B.V.
    Alicon
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Uterine Fibroid Embolization
    Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
    Liver Tumor Embolization
    Trauma Embolization
    Others
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

    Buy now